JPH0248028B2 - - Google Patents

Description

[Detailed description of the invention]

The present invention relates to lactone-based color-forming dyes, methods for producing the dyes, and pressure- and heat-sensitive materials containing them. Color-forming systems used in pressure-sensitive recording materials typically employ a substantially colorless color-forming dye, a color-forming agent that reacts with the color-forming dye to form a color, and a solvent in which the color-forming reaction is carried out. The reactive components of the color-forming system are isolated until use by microencapsulating the solvent solution of the color-forming dye. During use, these microcapsules are destroyed by the pressure exerted locally on the recording material, and the release of the chromogenic dye then occurs. Furthermore, the two color-forming components are brought into reactive contact and form a colored image that corresponds precisely to the shape of the applied pressure. In this way, the pressure sensitive recording material can provide reproduction without the need for any carbon paper. In self-contained recording systems, the recording material comprises a sheet provided with a coating of a microencapsulated chromogen solution in admixture with a color former. It is also possible to diffuse the microencapsulated color-forming dye solution and color-forming agent into the sheet itself. At least two types of recording materials are used in transfer recording systems. One has a sheet (CB sheet) provided with a coating of a microencapsulated color-forming dye solution, and the other has a sheet (CF sheet) provided with a coating of a color-forming agent. The sheets are set in the same way as a copying set with the coating adjacent, and the transfer of the chromogenic dye solution is effected from the CB sheet to the CF sheet. For further copying, the copying set includes a third recording material consisting of a sheet having on one side a coating of a microencapsulated chromogenic dye solution and a coating of a color former on the other side. Further inclusions are possible. One or more of these sheets (CFB sheets) are placed between the CF sheet and the CB sheet in a copying set, with each microcapsule coating adjacent to the color former coating. Various forms of lactone-based chromogenic dyes are known in color-forming systems for pressure-sensitive recording materials, e.g. U.S. Pat.
No. 3509173, No. 3540909, No. 3540911, No. 3540912, No. 3736337, No. 3775424,
No. 3,853,869 and No. 4,020,068, US Reissue Patent No. 23,024, and Belgian Patent No. 844,962. However, research continues into more and better color-forming dyes for a broader selection and improvement in color formation. A new type of chromogenic dye has been discovered which is suitable for use as a heat sensitive recording material as well as a pressure sensitive recording material. The chromogenic dye is initially substantially colorless, but reacts with the color former to produce a deep color. Furthermore, the chromogenic dye produces substantially the same color on different forms of acidic color formers, such as resins and clays. The resulting color is substantially resistant to actinic radiation, ie, has substantial fade resistance. The present invention provides a lactone-based color-forming dye having a heterocyclic substituent containing two condensed rings sharing a nitrogen atom. This color-forming dye is preferably represented by the formula (). In the formula, A is a substituent of formula (), or a substituent of formula (). In the formula, R ₁ and R ₂ are the same or different groups,
Each is hydrogen, alkyl, aryl, aralkyl or alkaryl. Or, one of R ₁ and R ₂ is cycloalkyl and the other is hydrogen.
Also, R ₁ and R ₂ together with the nitrogen atom to which they are bonded form a ring optionally containing an oxygen atom. Also, R ₁ represents the nitrogen atom to which it is bonded and
Forms a ring together with C ₄ and C ₃ atoms. Also, R ₂ is
It is hydrogen or alkyl and forms a ring with the nitrogen atom and the _C4 and _C5 atoms to which it is attached. _R3
is hydrogen, halogen or alkoxy. R ₄ and R ₅ are the same or different groups, hydrogen,
Alkyl or aryl. B is a heterocyclic substituent containing two fused rings sharing a nitrogen atom. And E is

【formula】

【formula】

【formula】

【formula】 or

[Formula] is. In the formula, R ₆ is hydrogen, halogen or dialkylamino, and n is 1-4. R ₇ is hydrogen or halogen. A heterocyclic substituent has only two fused aromatic rings (optionally substitutable) or additionally has a benzo group. In either case, the fused aromatic ring is generally a 5- or 6-membered ring, optionally containing nitrogen or other heteroatoms such as sulfur in one or the other ring in addition to one nitrogen atom at the point of fusion. Contains in. Examples of heterocyclic substituents include imidazo{2,1
-b}thiazole, pyrrolo{1,2-a}benzimidazole, imidazo{1,2-a}pyridine, pyrrolo{2,1-b}benzothiazole, pyrrolo{1,2-a}indole, pyrrolo{1 ,2
-a}imidazole, imidazo{2,1-a}isoquinoline, pyrrolo{1,2-a}quinoxaline, or imidazo{1,2-a}pyrimidine. Preferably, the imidazo{2,1-b}thiazole is of formula (), The pyrrolo{1,2-a}benzimidazole is of the formula (), or The imidazo{1,2-a}pyridine is of formula (XI), The pyrrolo{2,1-b}benzothiazole is of formula (X), or The pyrrolo{1,2-a}indole has the formula (X
) and The pyrrolo{1,2-a}imidazole is of formula (X), or The imidazo{2,1-a}isoquinoline is of formula (XV),

[Formula] The pyrrolo{1,2-a}quinoxaline is of formula (X), or The imidazo{1,2-a}pyrimidine is of formula (X). In each of the above formulas, R ₈ is optionally substituted aryl or alkyl, R ₉ is hydrogen or alkyl, R ₁₀ is hydrogen, alkyl or aryl, R ₁₁ , R ₁₂ , R ₁₃ and
R ₁₄ are the same or different groups, each hydrogen, alkyl or nitrogen, and R ₁₅ is alkyl. Within formula (), there are preferred chromogenic dyes that are divided into a number of subclasses. These subclasses are as follows, with E, A, and B representing the formulas specified and described above in their respective columns.

【table】

Table: The third subclass of formula () has some particularly useful chromogenic dyes, especially when E is of formula (),
It is useful when A is the formula () and B is the formula (Xa). The alkyl group or alkyl moiety of the alkyl-containing group used in the present invention is usually 1 to 12, for example 1 to 12.
It has 5 carbon atoms. Furthermore, such groups or moieties may have branched chains, such as isopentyl, but preferably have straight chains, such as n-butyl, especially methyl and ethyl. R ₁ or
Preferably, the cycloalkyl group used for R ₂ has 6 carbon atoms. The aryl group or aryl moiety of the aryl-containing group used in the present invention is preferably phenyl. R ₁
Aralkyl and alkaryl groups used for and/or R ₂ are benzyl and tolyl. The following substituents are included in the definition of formula (). 1 4-morpholinophenyl 2 Cairolyl substituent of formula (XV) and 3 diurolidinyl substituent of formula (X) When R ₈ is substituted phenyl, the phenyl group is
For example, substitution in the para position by methoxy or dimethylamino is preferred. Chromogenic dyes of formula () wherein B is formula (Xa), (XXa), (Xa) or (Xa), wherein B is formula (Xb), (Xb), (Xb) or (Xb), respectively It is a positional isomer of a chromogenic dye.
Generally, chromogenic dyes of the formula having the symbol "a" are preferred. The present invention also provides a method for producing the color-forming dye of the formula (). The method of the present invention involves preparing a keto acid of formula (XX) in the presence of a dehydrating agent. It consists of reacting with a compound of formula (XXI). N-H (XXI) In the formula, one of M and N is A, the other is B,
A, B and E are as defined above. Preferably M is A and N is B. The dehydrating agent is preferably an anhydride such as acetic anhydride, and is usually used in equimolar amounts with the reactants. When M is A of formula (), the keto acid is described in U.S. Pat.
3491116, 3509173, 3775424, 3936564, 4020068 and 4022771 and Belgian Patent No. 844962. When M is B, the keto acid is prepared by analogous means. When N is B of formula (XXI), the compound is prepared by methods analogous to one or more of the methods disclosed in the following references. 1 T. Uchida and K. Matsumoto, Synthesis 209 (1976) and references therein. 2 NPBuu-Hoi
et al., Journal of Organic Chemistry (J.Org.Chem.) 19, 1370 (1954). 3 J.Fisher and J.Straley, British Patent No.
1159691 No. 4 NPBuu-Hoi,
Nguyen-Dat-Uong
Xuong) and Ta-Thu-
Cuc), Bull.Soc.Chim.France,
1277 (1966). 5 RMPalei and PMKochergin,
Khimia Geterotsikl. Soedemenia (Khim.Geterotsikl.Soed) 536 (1967). 6 F. Kroehnke and W. Zecher, Ber, 95, 1128 (1962). 7 A. Druyhinina, P.
P.Kochergin and N.Bychkove, Khin.Geterotshikl
Soed), 856 (1969). 8. F. Kroehnke and W. Friedrich, Ber 96, 1195 (1963). 9 G.W.H.Cheeseman and B.T.
Tuck), Journal of the Chemical Society (J.Chem.Soc.) 3678 (1965). When N is A, the compounds are generally well known and are prepared by methods known in the art. The chromogenic dyes of the present invention can be used alone or in combination with other known chromogenic dyes, such as known phthalides, fluorans or spiropyrans. Examples of such known materials include 3,7
-Bis(dimethylamino)-10-benzoyl-phenothiazine (benzoyl leuco methylene
Blue, BLMB); 3,3-bis(dimethylaminophenyl)-6-dimethylaminophthalide (crystal violet lactone, CVL); 2'-
Anilino-6'-diethylamino-3'-methylfluorane (N102); 3,3-bis(1-ethyl-2
-Methylindol-3-yl)phthalide (indolyl); 3,3-bis(1-butyl-2)
-methylindol-3-yl)phthalide; spiro-7-chloro-2,6-dimethyl-3-ethylaminoxanthene-9,2-(2H)naphthol(1,8-bc)furan; 7-chloro-6 -Methyl-3-diethylamino-2-ethoxyno-3-
(2-methyl-1-ethylindol-3-yl)
Phthalide; 3-(4-diethylamino-2-butoxy)-3-(2-methyl-1-ethylindol-3-yl)phthalide; 3-(4-diethylamino-2-butoxy)-3-(2-methyl -1-ethylindol-3-yl)phthalide; and 3,7
-bis(diethylamino)-10-benzoyl-benzoxazine. The chromogenic dyes of the present invention, alone or in combination with other known materials, are typically dissolved in a suitable organic solvent prior to microencapsulation. Examples of such solvents are dialkyl phthalates containing alkyl groups having 4 to 13 carbon atoms, such as dibutyl, dioctyl and ditridecyl phthalate;
2,4-trimethyl-1,3-pentanediol di-i-butyrate (TXIB, U.S. Patent No.
4027065); ethyldiphenylmethane (U.S. Pat. No. 3996405); alkyl biphenyls such as mono-i-propylbiphenyl (U.S. Pat. No. 3627581);
_C10 - _C14 alkylbenzenes such as dodecylbenzene; di(aralkyl)ethers such as diaryl ethers and dibenzyl ethers such as diphenyl ether; and aryl alkyl ethers such as phenylbenzyl ether. ; liquid dialkyl ethers having at least 8 carbon atoms; liquid alkyl ketones having at least 9 carbon atoms; alkyl or aralkyl benzoates such as benzyl benzoate;
and partially hydrogenated terphenyl. All of these solvents are substantially colorless and
Used alone or in combination. They can be used with diluents to reduce the cost of chromogen solutions. The diluent must not chemically react with the solvent or other components and, of course, must be at least partially miscible with the solvent to provide a single phase. The diluent is used in an amount that achieves cost effectiveness but does not compromise the solubility of the chromogenic material. Diluents are known in the art, and a preferred example is Magnaflux oil. This Magnaflux oil is a mixture of saturated aliphatic hydrocarbon oils with a distillation temperature of 320-550°. Further, the present invention provides a microencapsulated color-forming dye solution using the color-forming dye of the present invention. Microencapsulation of chromogenic dye solutions is accomplished using known encapsulation methods, e.g.
It is carried out by the method disclosed in No. 2800457, No. 3041289, No. 3533958, No. 3755190, No. 4001140, and No. 4100103. Color formers used in the present invention include any type of acidic substance that falls within the definition of a Lewis acid or electron acceptor. Such acidic materials include clays such as attapulgite, bentonite and montmorillonite; processed clays such as the silton clay disclosed in U.S. Pat. Zinc sulfate, zinc sulfide, calcium sulfate, calcium citrate, calcium phosphate, calcium fluoride and barium sulfate, aromatic carboxylic acids such as salicylic acid, U.S. Pat.
Derivatives of aromatic carboxylic acids and their metal salts, as disclosed in No. 4022936, and phenol-formaldehyde polymers, phenol-acetylene polymers, maleic acid-rosin resins, partially or fully hydrolyzed styrene-maleic acid. Anhydride cochromatic polymers, ethylene-maleic anhydride copolymers, carboxypolymethylene and fully or partially hydrolyzed vinyl methyl ether-maleic anhydride copolymers disclosed in U.S. Pat. No. 3,672,935. and mixtures thereof. An example of a color former composition is as follows. Weight % zinc modified phenolic polymer 13.6 Paper coated kaolin 67.9 Calcium carbonate 6.0 Styrene-butadiene latex 6.0 Etherified cornstarch 6.5 Recording sheets coated with metal modified phenolic resins are disclosed in U.S. Pat. No. 3,732,120. The present invention provides a pressure-sensitive or heat-sensitive recording material containing the color-forming dye described above. Coating compositions for pressure-sensitive recording materials and methods for their formation are generally known in the art, and are described, for example, in U.S. Pat. No. 3,627,581, U.S. Pat.
Disclosed in the issue. Coating constructions for heat-sensitive recording materials and their formation methods are generally known in the art and are disclosed, for example, in US Pat. Hereinafter, the present invention will be explained in more detail with reference to production examples of color-forming dyes. These production examples can be organized into Examples of the present invention and other reference examples as follows. .

[Table] In addition, "parts" in each production example mean "parts by weight." Production example 1 3-(1-ethyl-2-methylindole-3
-yl)-3-(6-p-methoxyphenyl-imidazo{2,1-b}thiazol-5-yl)
Preparation of phthalide. 1.23 grams of 6-p-methoxyphenylimidazo{2,1-b}thiazole and 0.92 grams of (1
-ethyl-2-methylindol-3-yl)
A solution of (2-carboxy-phenyl)-ketone and 30 ml of acetic anhydride was stirred at 50-55°C for 3 hours. The reaction mixture was poured into 300ml of water and the pH was adjusted to 9.8 with ammonium hydroxide. The resulting solid was filtered and washed with water to yield 2.1 grams of product with a melting point of 115-120°C. Application of a chloroform solution of the product to recording sheet material containing Silton Clay gave a purple color. Production Examples 2 to 12 A keto acid of formula (XX) where M is A and a compound of formula (XXI) where N is B are mixed with acetic anhydride,
Additional experiments were performed with heating. The reaction mixture was cooled, treated with dilute ammonium hydroxide and extracted with toluene. The table shows the colors produced when toluene extracts of the reactants and reaction products are applied to recording sheet material coated with Silton Clay. Production example 13 3-(4-diethylamino-2-ethoxyphenyl)-3-(2-(p-dimethyl-aminophenyl)imidazo{1,2-a}pyridine-3-
Preparation of yl)phthalide 0.35 grams of 2-(p-dimethylaminophenyl)imidazo{1,2-a}pyridine and 0.47 grams of 2-ethoxy-4-diethylamino-2'-carboxybenzophenone and 6 ml of anhydrous The mixture with acetic acid was heated at 50°C for 2 hours with stirring. The reaction mixture was left overnight and poured into 100ml water the next day. The PH of the mixture was adjusted to 9.8 with ammonium hydroxide. The benzene extract of the mixture was evaporated under reduced pressure to yield 0.78 grams of product. The product showed a strong lactone carbonyl infrared spectrum peak at 1755 cm ^-1 . The ether extract of the product was chromatographed on a microalumina column. A chloroform solution of this purified product produced a blue color when applied to Silton Clay coated recording sheet material. Preparation Examples 14-19 By substantially the same method as described in Preparation Example 13, a keto acid of formula (XX) was heated in the presence of acetic anhydride to form a compound of formula (XXI) substantially were reacted with equimolar amounts. A solid product separated and was recrystallized to a constant melting point. A chloroform solution of this product was used to produce color in recording sheet material or silica gel coated with zinc-modified phenolic resin or Silton clay. These reactants and their results are shown in the table. Preparation Examples 20-56 Additional experiments were conducted by mixing the keto acid of formula (XX), the compound of formula (X), and acetic anhydride and heating. The reaction mixture was cooled, treated with dilute ammonium hydroxide, and extracted with toluene. The table shows the color produced when the combination of reactants and the toluene extract of the reaction product are applied to recording sheet material or silica gel coated with zinc-modified phenolic resin or silton clay. In the following production example for the preparation of chromogenic dyes of the pyridinoline and quinolinone type (i.e. where E of formula () has the formula () or (), respectively) from pyridinyl and quinolinyl ketoacids:
Each reaction yields a mixture of two positional isomers. Unless stated otherwise, the naming of one isomer for the keto acids and chromogenic dyes of formula (XX) is understood to be a mixture of the two isomers. For example, the ketoacid (1-ethyl-2-methylindol-3-yl)(3-carboxypyridin-2-yl)ketone of Preparation Example 57 is in fact the named compound and its isomer (1-ethyl- 2-methylindol-3-yl)(2-carboxypyridine-
3-yl)ketone. Similarly, the chromogenic dye of Production Example 57, 7-(1-ethyl-2-methylindol-3-yl)-7-(6-p-methoxyphenylimidazo-{2,1-b}thiazole-5 -yl)-5,7-dihydrofuro{3,4
-b}pyridin-5-one is, in fact, the named material and its isomers, 5-(1-ethyl-2-methylindol-3-yl)-5-(6-p-methoxyphenylimidazo{ 2,1-b}thiazole-
5-yl)-5,7-dihydrofuro{3,4-b}
It is a mixture of pyridin-7-ones. Production example 57 7-(1-ethyl-2-methylindole-3
-yl)-7-(6-p-methoxy-phenylimidazo{2,1-b}thiazol-5-yl)
Preparation of -5,7-dihydrofuro{3,4-b}pyridin-5-one. 0.92 grams of 6-p-methoxyphenylimidazo{2,1-b}thiazole and 0.69 grams of (1
-ethyl-2-methylindol-3-yl)
(3-carboxypyridin-2-yl)ketone and
A mixture of 20 ml of acetic anhydride was stirred at 50° C. for 2.5 hours. The reaction solution was poured into 250 ml of water, and the pH was adjusted to 9.8 with ammonium hydroxide. After stirring for 1 hour, the solids were filtered and washed with water to yield 1.44 grams (95%) of the desired product, melting point 115-118°C. The infrared spectrum showed a strong lactone carbonyl peak at 1770 cm ^-1 . The product solution showed a purple color on silica gel. Production Examples 58-60 In substantially the same manner as described in Production Example 57, (1-ethyl-2-methylindole-3-
yl)(3-carboxypyridin-2-yl)ketone was reacted with a substantially equimolar amount of a compound of formula (XXI) in the presence of acetic anhydride under heat. The reaction products were separated. Solutions of each reaction product were used to produce color on recording sheet materials coated with zinc-modified phenolic resin or Silton clay.
The results are shown in the table. Examples 61-68 Additional experiments were conducted by mixing and heating the keto acid of formula (XX), the compound of formula (XXI), and acetic anhydride. The reaction mixture was cooled, treated with dilute ammonium hydroxide and extracted with toluene. The table shows the colors that result when a toluene extract of the reaction product is applied to recording sheet material coated with the reactants and zinc-modified phenolic resin or Silton Clay. Production example 69 5-(4-diethylamino-2-ethoxyphenyl)-5-(8-methyl-2-phenylimidazo{1,2-a}pyridin-3-yl)-5,
7-dihydrofuro{3,4-b}pyridine-7
- Preparation of on. 1.04 grams of 8-methyl-2-phenylimidazoindole {1,2-a}pyridine and 1.71 grams of (4-diethylamino-2-ethoxyphenyl)(3-carboxypyridin-2-yl)ketone and 25 ml of The acetic anhydride was heated at 55° C. for 1 hour and left at room temperature for 18 hours. The reaction solution was poured into a solution of 100 ml water and 50 ml 58% ammonium hydroxide. After stirring for 1 hour, the cream-colored solid was removed by filtration and washed with water to give a product with a melting point of 128-132°C.
Got a gram. Thin layer chromatography on silica gel showed large blue dots and small blue dots. These were isomeric dyes from the keto acid isomer mixture used. The infrared spectrum is
It showed a strong carbonyl lactone peak at 1770 cm ^-1 . A portion was recrystallized from toluene/petroleum ether to give an analytical sample with a melting point of 221-223°C. A chloroform solution of the product exhibited a blue color when applied to recording sheet material coated with Silton Clay. Production Examples 70-81 By substantially the same method as disclosed in Production Example 69, (4-diethylamino-2-ethoxyphenyl)(3-carboxypyridin-2-yl)
The ketone was reacted with a substantially equimolar amount of a compound of formula (XXI) in the presence of acetic anhydride under heat. The reaction products were liberated and a solution of each product was used for color development on recording sheet material coated with zinc-modified phenolic resin or Silton clay or on silica gel. The table shows the compound of formula (XXI) used and the experimental results obtained. Examples 82-105 Additional experiments were performed in which a keto acid of formula (XX) and a compound of formula (XXI) were mixed with acetic anhydride and heated. The reaction mixture was cooled, treated with dilute ammonium hydroxide and extracted with toluene. The table shows the respective color development when the set of reactants and the toluene extract of the reaction products are applied to recording sheet material or silica gel coated with zinc-modified phenolic resin or silton clay. Production example 106 1-(4-diethylamino-2-ethoxyphenyl)-1-(8-methyl-2-phenylimidazo{1,2-a}pyridin-3-yl)-1,
Preparation of 3-dihydrofuro{3,4-b}quinoxalin-3-one. 3.9 grams of (4-diethylamino-2-ethoxyphenyl)(3-carboxyquinoxaline-
2-yl)ketone and 2.1 grams of 8-methyl-2
-phenylimidazo-{1,2-a}pyridine and
1.5 ml of acetic anhydride was heated at 80° C. for 1 hour and poured onto a mixture of glacial ammonia and toluene. The toluene portion was separated, washed with saturated sodium sulfate solution, filtered through phase separation paper and concentrated. Petroleum ether was added to the concentrate and 2.7 grams of crystals were separated. This crystalline fraction was recrystallized four times from a mixture of toluene and petroleum ether to obtain a final product with a melting point of 135-136°C. Solutions of the product exhibited a blue color when applied to recording sheet materials coated with zinc-modified phenolic resin or Silton clay. Preparation Examples 107-111 Additional experiments were performed by mixing the keto acid of formula (XX) and the compound of formula (XXI) with acetic anhydride and heating. The reaction mixture was cooled, treated with dilute ammonium hydroxide and extracted with toluene. The table shows the set of reactants and their respective color development when the toluene extract of the reaction product is applied to Silton Clay coated recording sheet material.

【table】

【table】

[Table] Cibenzophenone

[Table] Benzophenone

[Table] Benzophenone Benzimidazole

【table】

【table】

[Table] Rule
Knoll resin

【table】

[Table] (Reference) Rule
Knoll resin

[Table] (Reference)

[Table] (Reference) Thiazole
111 〃 4〓Ethyl〓
2〓Phenyl〓4H〓Pirolo〓1,2〓a〓 Green〃
(Reference) Benzimidazole Existing novel color-forming dyes prepared by the method described in the above examples are as follows. Production example Chromogenic dye 1 3-(1-ethyl-2-methylindol-3-yl)-3-(6-p-methoxy-phenylimidazo {1,2-
b}thiazol-5-yl)phthalide 2 3-(1-ethyl-2-methylindol-3-yl)-3-(4-ethyl-
2-phenyl-4H-pyrrolo{1,2
-a}benzimidazol-1-yl)phthalide 3 3-(1-ethyl-2-methylindol-3-yl)-3-(8-methyl-
2-phenylimidazo {1,2-a}
Pyridin-3-yl)phthalide 4 3-(1-ethyl-2-methylindol-3-yl)-3-(6-phenylimidazo{2,1-b}thiazole-
5-yl)phthalide 5 3-(1-ethyl-2-methylindol-3-yl)-3-(2-(p-methoxyphenyl)imidazo{1,2-
a}pyridin-3-yl)phthalide 6 3-(1-ethyl-2-methylindol-3-yl)-3-(2-phenylimidazo{1,2-a}pyridine-3
-yl)phthalide 7 3-(1-ethyl-2-methylindol-3-yl)-3-(2-phenylpyrrolo{2,1-b}benzothiazol-1-yl)phthalide 8 3-(1-ethyl -2-methylindol-3-yl)-3-(4-ethyl-
2-phenyl-4H-pyrrolo{1,2
-a}benzimidazol-1-yl)phthalide 9 3-(1-ethyl-2-methylindol-3-yl)-3-(2-(p-methoxyphenyl)imidazo{1,2-
a}Pyridin-3-yl)phthalide 10 3(1-ethyl-2-methylindol-3-yl)-3-(2-phenyl-
imidazo{1,2-a}pyridine-3
-yl)phthalide 11 3-(1-ethyl-2-methylindol-3-yl)-3-(6-p-methoxyphenyl)imidazo{2,1-
b}thiazol-5-yl)phthalide 12 3-(1-ethyl-2-methylindol-3-yl)-3-(2-phenylpyrrolo{2,1-b}benzothiazol-1-yl)phthalide 13( Reference) 3-(4-diethylamino-2-ethoxyphenyl)-3-(2-(p-dimethylaminophenyl)imidazo {1,2
-a}pyridin-3-yl)phthalide 14 (reference) 3-(2-ethoxy-4-diethylaminophenyl)-3-(8-methyl-2-
Phenylimidazo{1,2-a}pyridin-3-yl)phthalide 15 (reference) 3-(2-ethoxy-4-diethylaminophenyl)-3-(6-p-methoxyphenyl)imidazo{2,1- b}thiazol-5-yl)phthalide 16 (reference) 3-(2-ethoxy-4-diethylaminophenyl)-3-(4-ethyl-1-
Methyl-2-phenyl-4H-pyrrolo{1,2-a}benzimidazole-
3-yl)phthalide 17 (reference) 3-(2-ethoxy-4-diethylaminophenyl)-3-(4-ethyl-2-
Phenyl-4H-pyrrolo{1,2-a}
Benzimidazol-1-yl)phthalide 18 (Reference) 3-(4-diethylamino)-3-(2-
Phenyl-9,9-dimethyl-9H-
pyrrolo{1,2-a}indole-1
-yl)phthalide 19 (reference) 3-(2-ethoxy-4-diethylaminophenyl)-3-(1-ethyl-6-
Phenyl-1H-pyrrolo{1,2-a}
Imidazol-5-yl)phthalide 20 (reference) 3-(4-diethylaminophenyl)-
3-(4-ethyl-2-phenyl-4H
-pyrrolo{1,2-a}benzimidazol-1-yl)phthalide 21 (reference) 3-(4-diethylaminophenyl)-
3-(1-methyl-2-phenyl-4
-ethyl-4H-pyrrolo{1,2-a}
Benzimidazol-3-yl)phthalide 22 (reference) 3(4-diethylaminophenyl)-3
-(8-Methyl-2-phenylimidazo{1,2-a}pyridin-3-yl)phthalide 23 (reference) 3-(4-diethylaminophenyl)-
3-(6-phenylimidazo{2,1
-b}thiazol-5-yl)phthalide 24 (reference) 3-(4diethylaminophenyl)-3
-(2-(p-methoxyphenyl)-imidazo{1,2-a}pyridine-3-
yl) phthalide 25 (reference) 3-(4-diethylaminophenyl)-
3-(4-ethyl-2phenyl-4H-
Pyrrolo{1,2-a}benzimidazol-1-yl)-4,5,6,7-
Tetrachlorophthalide 26 (reference) 3-(4-diethylaminophenyl)-
3-(2-phenyl-9,9-dimethyl-9H-pyrrolo{1,2-a}indol-1-yl)-4,5,6,7
-Tetrachlorophthalide 27 (reference) 3-(4-diethylaminophenyl)-
3-(1-methyl-2phenyl-4-
Ethyl-4H-pyrrolo{1,2-a}
benzimidazol-3-yl)-4,
5,6,7-tetrachlorophthalide 28 (reference) 3-(4-diethylaminophenyl)-
3-(8-Methyl-2-phenylimidazo{1,2-a}pyridin-3-yl)-4,5,6,7-tetrachlorophthalide 29 (Reference) 3-(4-diethylaminophenyl)-
3-(6-phenylimidazo{2,1
-b}thiazol-5-yl)-4,
5,6,7-tetrachlorophthalide 30 (reference) 3-(4-diethylaminophenyl)-
3-(2-(p-methoxyphenyl)imidazo{1,2-a}pyridine-3-
yl)-4,5,6,7-tetrachlorophthalide 31 (reference) 3-(4-diethylaminophenyl)-
3-(4-ethyl-2-phenyl-4H
-pyrrolo{1,2-a}benzimidazol-1-yl)-6 dimethylaminophthalide 32 (reference) 3-(4-dimethylaminophenyl)-
3-(2-phenyl-9,9-dimethyl-9H-pyrrolo{1,2-a}indol-1-yl)6-dimethylaminophthalide 33 (Reference) 3-(4-dimethylaminophenyl)-
3-(1-methyl-2-phenyl-4
-ethyl-4H-pyrrolo{1,2-a}
benzimidazol-1-yl)-6
-Dimethylaminophthalide 34 (reference) 3-(4-dimethylaminophenyl)-
3-(8-methyl-2-phenyl-imidazo{1,2-a}pyridine-3-
yl)-6-dimethylaminophthalide 35 (reference) 3-(4-dimethylaminophenyl)-
3-(6-phenylimidazo{2,1
-b}thiazol-5-yl)-6-
Dimethylaminophthalide 36 (reference) 3-(4-dimethylaminophenyl)-
3-(2-(p-methoxyphenyl)imidazo{1,2-a}pyridine-3-
yl)-6-dimethylaminophthalide 37 (reference) 3-(2-methoxy-4-N-methyl-
N-p-tolylaminophenyl)-3
-(4-ethyl-2-phenyl-4H-
Pyrrolo{1,2-a}benzimidazol-1-yl)phthalide 38 (reference) 3-(2-methoxy-4-N-methyl-
N-p-tolylaminophenyl)-3
-(2-phenyl-9,9-dimethyl-9H-pyrrolo{1,2-a}indol-1-yl)phthalide 39 (reference) 3-(2-methoxy-4-N-methyl-
N-p-tolylaminophenyl)-3
-(1-methyl-2-phenyl-4-
Ethyl-4H-pyrrolo{1,2-a}
Benzimidazol-3-yl)phthalide 40 (Reference) 3-(2-methoxy-4-dimethylaminophenyl)-3-(4-ethyl-2-
Phenyl-4H-pyrrolo{1,2-a}
benzimidazole) 4,5,6,7
-Tetrachlorophthalide 41 (Reference) 3-(2-methoxy-4-diethylaminophenyl)-3-(1-methyl-2-
Phenyl-4-ethyl-4H-pyrrolo{1,2-a}benzimidazole-
3-yl)-4,5,6,7-tetrachlorophthalide 42 (Reference) 3-(2-methoxy-4-cyclohexylaminophenyl)-3-(4-ethyl-2-phenyl-4H-pyrrolo {1,
2-a}benzimidazol-1-yl)phthalide 43 (reference) 3-(2-methoxy-4-cyclohexylaminophenyl)-3-(2-phenyl-9,9-dimethyl-9H-pyrrolo{1, 2-a}indol-1-yl)
Phthalide 44 (Reference) 3-(2-methoxy-4-cyclohexylaminophenyl)-3-(1-methyl-2-phenyl-4-ethyl-4H-
Pyrrolo{1,2-a}benzimidazol-3-yl)phthalide 45 (Reference) 3-(2-n-butoxy-4-diethylaminophenyl)-3-(4-ethyl-
2-phenyl-4H-pyrrolo{1,2
-a}benzimidazol-1-yl)phthalide 46 (reference) 3-(2-n-butoxy-4-diethylaminophenyl)-3-(2-phenyl-9,9-dimethyl-9H-pyrrolo{1, 2-a}indol-1-yl)
Phthalide 47 (Reference) 3-(2-n-butoxy-4-diethylaminophenyl)-3-(1-methyl-
2-phenyl-4-ethyl-4H-pyrrolo{1,2-a}benzimidazol-3-yl)phthalide 48 (reference) 3-(4-morpholinophenyl)-3-
(4-Ethyl-2-phenyl-4H-pyrrolo{1,2-a}benzimidazol-1-yl)phthalide 49 (Reference) 3-(4-morpholinophenyl)-3-
(2-phenyl-9,9-dimethyl-
9H-pyrrolo{1,2-a}indol-1-yl)phthalide 50 (reference) 3-(4-morpholinophenyl)-3-
(1-Methyl-2-phenyl-4-ethyl-4H-pyrrolo{1,2-a}benzimidazol-3-yl)phthalide 51 (Reference) 3-(2-methoxy-4-diethylaminophenyl)-3 -(4-ethyl-2-
Phenyl-4H-pyrrolo{1,2-a}
Benzimidazol-1-yl)phthalide 52 (Reference) 3-(2-methoxy-4-diethylaminophenyl)-3-(2-phenyl-
9,9-dimethyl-9H-pyrrolo{1,
2-a}indol-1-yl)phthalide 53 (reference) 3-(2-methoxy-4-diethylaminophenyl)-3-(1-methyl-2-
Phenyl-4-ethyl-4H-pyrrolo{1,2-a}benzimidazole-
3-yl)phthalide 54 (reference) 3-(2-methoxy-4-diethylaminophenyl)-3-(8-methyl-2-
Phenylimidazo{1,2-a}pyridin-3-yl)phthalide 55 (reference) 3-(2-methoxy-4-diethylaminophenyl)-3-(6-phenyl-imidazo{2,1-b}thiazole- 5
-yl)phthalide 56 (reference) 3-(2-methoxy-4-diethylaminophenyl)-3-(2-p-methoxy-phenyl)imidazo{1,2-a}
Pyridin-3-yl)phthalide 57 7-(1-ethyl-2-methylindol-3-yl)-7-(6-p-methoxy-phenylimidazo{2,1-
b}thiazol-5-yl)-5,7
-dihydrofuro{3,4-b}pyridin-5-one 58 7-(1-ethyl-2-methylindol-3-yl)-7-(2-phenylpyrrolo{2,1-b}benzothiazole-1- yl)-5,7-dihydrofuro{3,4-b}pyridin-5-one 59 7-(1-ethyl-2-methylindol-3-yl)-7-(4-ethyl-
2-phenyl-4H-pyrrolo{1,2
-a}benzimidazol-1-yl)-5,7-dihydrofuro{3,4
-b}pyridin-5-one 60 7-(1-ethyl-2-methylindol-3-yl)-7-(2-phenylimidazo{1,2-a}pyridine-3
-yl)-5,7-dihydrofuro{3,
4-b}Pyridin-5-one 61 7-(1-ethyl-2-methylindol-3-yl)-7-(8-methyl-
2-phenylimidazo {1,2-a}
pyridin-3-yl)5,7-dihydro{3,4-b}pyridin-5-one 62 7-(1-ethyl-2-methylindol-3-yl)-7-(6-phenylimidazo{1, 2-a}thiazole-
5-yl)-5,7-dihydrofuro{3,4-b}pyridin-5-one 63 7-(1-ethyl-2-methylindol-3-yl)-7-(2-(p-methoxyph) enyl) imidazo {1,2-
a}pyridin-3-yl)-5,7-
Dihydrofuro{3,4-b}pyridin-5-one 64 7-(1-i-pentyl-2-methylindol-3-yl)-7-(4-ethyl-2-phenyl-4H-pyrrolo{1, 2-a}Benzimidazole-
1-yl)-5,7-dihydrofuro{3,4-b}pyridin-5-one 65 7-(1-i-pentyl-2-methylindol-3-yl)-7-(2-
(p-methoxyphenyl)imidazo{1,2-a}pyridin-3-yl)-
5,7-dihydrofuro{3,4-b}
Pyridin-5-one 66 7-(1-i-pentyl-2-methylindole)-7-(2-phenylimidazo{1,2-a}pyridin-3-yl)-5,7-dihydrofuro{3,4
-b}Pyridin-5-one 67 7-(1-i-pentyl-2-methylindol-3-yl)-7-(6-
(p-methoxy-phenyl)imidazo{2,1-b}thiazol-5-yl)
-5,7-dihydrofuro{3,4-
b}Pyridin-5-one 68 7-(1-i-pentyl-2-methylindol-3-yl)-7-(2-phenyl-pyrrolo{2,1-b}benzothiazol-1-yl)- 5,7-dihydrofuro{3,4-b}pyridine-
5-one 69 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5-(8-methyl-2-
Phenylimidazo{1,2-a}pyridin-3-yl)-5,7-dihydrofuro{3,4-b}pyridin-7-one 70 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)- 5-(2-phenyl-imidazo{1,2-a}pyridine-3-
yl)-5,7-dihydrofuro{3,
4-b}Pyridin-7-one 71 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5-(6-nitro-2-
Phenylimidazo{1,2-a}pyridin-3-yl)-5,7-dihydrofuro{3,4-b}pyridin-7-one 72 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)- 5-(2-(p-methoxyphenyl)imidazo{1,2-a}
pyridin-3-yl)-5,7-dihydrofuro{3,4-b}pyridine-7
-one 73 (reference) 5-(4-diethylamino-2-ethoxyphenyl)-5-(2-(p-dimethylaminophenyl)imidazo{1,2
-a}pyridin-3-yl)-5,7
-dihydrofuro{3,4-b}pyridin-7-one 74 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5-(2-phenyl-imidazo{2,1-a}isoquinoline-
5-(4-diethylamino-2-ethoxyphenyl)-5-(4-methyl-2-
Phenylpyrrolo{1,2-a}quinoxalin-1-yl)5,7-dihydrofuro{3,4-b}pyridin-7-one 76 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5 -(1-ethyl-6-
Phenylpyrrolo{1,2-a}imidazol-5-yl)-5,7-dihydrofuro{3,4-b}pyridin-7-one 77 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5 -(4-ethyl-1-
Methyl-2-phenylprolo{1,2
-a}benzimidazol-3-yl)-5,7-dihydrofuro{3,4
-b}Pyridin-7-one 78 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5-(4-ethyl-2-
Phenylpyrrolo{1,2-a}benzimidazol-1-yl)-5,7-
Dihydrofuro{3,4-b}pyridin-7-one 79 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5-(2-phenylimidazo{1,2-a}pyridin-3-yl) -5,7-dihydrofuro{3,4
-b}Pyridin-7-one 80 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5-(2-phenylpyrrolo{2,1-b}benzothiazole-
5-(4-diethylamino-2-ethoxyphenyl)-5-(6-(p-methoxyphenyl) enyl)imidazo{2,1-b}
thiazol-5-yl)-5,7-dihydrofuro{3,4-b}pyridine-
7-one 82 (Reference) 5-(4-diethylamino-2-ethoxyphenyl)-5-(6-phenylimidazo{2,1-b}thiazole-5-
yl)-5,7-dihydrofuro{3,
4-b}Pyridin-7-one 83 (Reference) 5-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)-5
-(4-methyl-1-methyl-2-phenyl-4H-pyrrolo{1,2-a}
benzimidazol-3-yl)-5,
7-dihydrofuro{3,4-b}pyridin-7-one 84 (Reference) 5-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)-5
-(8-methyl-2-phenylimidazo{1,2-a}pyridin-3-yl)-5,7-dihydrofuro{3,4
-b}Pyridin-7-one 85 (Reference) 5-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)-5
-(2-phenylimidazo{1,2-
a}pyridin-3-yl)-5,7-
Dihydrofuro{3,4-b}pyridin-7-one 86 (Reference) 5-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)-5
-(6-(p-methoxyphenyl)imidazo{2,1-b}thiazole-5-
yl)-5,7-dihydrofuro{3,
4-b}Pyridin-7-one 87 (Reference) 5-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)-5
-(2-phenylpyrrolo{2,1-b}
Benzothiazol-1-yl-5,7
-dihydrofuro{3,4-b}pyridin-7-one 88 (reference) 5-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)-5
-(4-Methyl-2-phenylpyrrolo{1,2-a}quinoxalin-1-yl)-5,7-dihydrofuro{3,4
-b}Pyridin-7-one 89 (Reference) 5-(2,3,6,7-tetrahydro-
1H, 5H-benzo{ij}quinoline-9
-yl)-5-(2-(p-methoxyphenyl)imidazo{1,2-a}pyridin-3-yl)-5,7-dihydrofuro{3,4-b}pyridin-7-one90( Reference) 5-(2,3,6,7-tetrahydro-
1H, 5H-benzo{ij}quinoline-9
-yl)-5-(2-phenylpyrrolo{2,1-b}benzothiazole-1
-yl)-5,7-dihydrofuro{3,
4-b}Pyridin-7-one 91 3-(1-ethyl-2-methylindol-3-yl)-3-(8-methyl-
2-phenylimidazo {1,2-a}
pyridin-3-yl)-1,3-dihydrofuro{3,4-b}quinoline-1
-one 92 3-(1-ethyl-2-methylindol-3-yl)-3-(6-phenylimidazo{2,1-b}thiazole-
5-yl)-1,3-dihydrofuro{3,4-b}quinolin-1-one 93 3-(1-ethyl-2-methylindol-3-yl)-3-(2-(p-methoxyf) enyl)imidazo{1,2-
a}pyridin-3-yl)-1,3-
Dihydrofuro{3,4-b}quinolin-1-one 94 3-(1-ethyl-2-methylindol-3-yl)-3-(2-phenylimidazo{1,2-a}pyridine-3
-yl)-1,3-dihydrofuro{3,
4-b}Quinolin-1-one 95 3-(1-ethyl-2-methylindol-3-yl)-3-(6-(p-methoxyphenyl)imidazo{2,1-
b}thiazol-5-yl)-1,3
-dihydrofuro{3,4-b}quinolin-1-one 96 3-(1-ethyl-2-methylindol-3-yl)-3-(2-phenylpyrrolo{2,1-b}benzothiazole-1- yl)-1,3-dihydrofuro{3,4-b}quinolin-1-one 97 (Reference) 3-(4-diethylamino-2-ethoxyphenyl)-3-(1-methyl-2-
Phenyl-4-ethyl-4H-pyrrolo{1,2-a}benzimidazole-
3-yl)-1,3-dihydrofuro{3,4-b}quinolin-1-one 98 1-(1-ethyl-2-methylindol-3-yl)-1-(8-methyl-
2-phenylimidazo {1,2-a}
pyridin-3-yl)-1,3-dihydrofuro{3,4-b}quinoxalin-3-one 99 1-(1-ethyl-2-methylindol-3-yl)-1-(6-phenylimidazo{2 ,1-b}thiazole-
5-yl)-1,3-dihydrofuro{3,4-b}quinoxalin-3-one 100 1-(1-ethyl-2-methylindol-3-yl)-1-(2-phenylimidazo{1,2 -a}pyridine-3
-yl)-1,3-dihydrofuro{3,
4-b}quinoxalin-3-one 101 1-(1-ethyl-2-methylindol-3-yl)-1-(2-(p-methoxyphenyl)imidazo{1,2-
a}pyridin-3-yl)-1,3-
Dihydrofuro{3,4-b}quinoxalin-3-one 102 1-(1-ethyl-2-methylindol-3-yl)-1-(6-(p-methoxyphenyl)imidazo{2,1-
b}thiazol-5-yl)-1,3
-dihydrofuro{3,4-b}quinoxalin-3-one 103 1-(1-ethyl-2-methylindol-3-yl)-1-(2-phenylimidazo{1,2-a}pyridine-3
-yl)-1,3-dihydrofuro{3,
4-b}-6-(and 7-)chloroquinoxalin-3-one 104 1-(1-ethyl-2-methylindol-3-yl)-1-(2-(p-methoxyphenyl)imidazo{ 1,2-
a}pyridin-3-yl)-1,3-
Dihydrofuro{3,4-b}-6-(and 7-)chloroquinoxalin-3-one 105 1-(1-ethyl-2-methylindol-3-yl)-1-(6-(p-methoxyf) enyl)imidazo{2,1-
b}thiazol-5-yl)-1,3
-dihydrofuro{3,4-b}-6-
(and 7-)chloroquinoxaline-3
-one 106 (Reference) 1-(4-diethylamino-2-ethoxyphenyl)-1-(8-methyl-2-
Phenylimidazo{1,2-a}pyridin-3-yl)-1,3-dihydrofuro{3,4-b}quinoxaline-3
-one 107 (Reference) 1-(4-diethylamino-2-ethoxyphenyl)-1-(6-phenylimidazo{2,1-b}thiazole-5-
yl)-1,3-dihydrofuro{3,
4-b} Quinoxalin-3-one 108 (Reference) 1-(4-diethylamino-2-ethoxyphenyl)-1-(2-(p-methoxyphenyl)imidazo{1,2-a}
1-(4-diethylamino-2-ethoxyphenyl)-1-(2-phenylimidazo{1) ,2-a}pyridin-3-yl)-1,3-dihydrofuro{3,4
-b} Quinoxalin-3-one 110 (Reference) 1-(4-diethylamino-2-ethoxyphenyl)-1-(6-(p-methoxyphenyl)imidazo {2,1-b}
Thiazol-5-yl)-1,3-dihydrofuro{3,4-b}quinoxalin-3-one 111 (Reference) 1-(4-diethylamino-2-chlorophenyl)-1-(4-ethyl-2-phenyl) -4H-pyrrolo {1,2-a}
benzimidazol-1-yl)-1,
3-Dihydrofuro{3,4-b}quinoxalin-3-one Elemental Analysis Elemental analysis of some of the chromogenic dyes was performed. The molecular formulas and calculated and experimentally determined analysis results of some materials are shown in the table.

【table】

[Table] Preparation of pressure-sensitive copying paper Ethyldiphenylmethane (US Patent No. 3996405)
Production Example 1, Production Example 17 during mixing of 64:36 weight ratio of No.) and saturated hydrocarbon oil (distillation range 370-500〓),
1.7% of the material in Production Example 58, Production Example 80 or Production Example 106
The solution was microencapsulated by the method of Preparation Example 17 of US Pat. No. 4,100,103. The resulting microcapsules were mixed with uncooked wheat flour starch particles and cooked corn starch binder, and the mixture was applied to a paper web and dried to obtain a pressure sensitive transfer paper. The resulting pressure-sensitive transfer paper (CB sheet) is placed facing a bottom paper (CF sheet) having a coating containing Silton clay as disclosed in US Pat. Nos. 3,622,364 and 3,753,761. Pressure is applied to this pair of CB sheet and CF sheet for marking.
A clear image as shown below was obtained. Color production example of CB sheet image with the following compounds 1 Purple 〃 17 Blue 〃 58 Blue Green 〃 80 Green 〃 106 Blue

Claims (1)

[Claims] 1 formula A lactone-based color-forming dye with However, in formula (), A is a substituent of formula (), [In formula (), R ₄ and R ₅ are the same or different groups, each of which is hydrogen, alkyl, or aryl. ] B is imidazo{2,1-b}thiazole, pyrrolo{1,2-a}benzimidazole, imidazo{1,2-a}pyridine, pyrrolo{2,1-b}
Benzothiazole, pyrrolo{1,2-a}indole, pyrrolo{1,2-a}imidazole, imidazo{2,1-a}isoquinoline, pyrrolo{1,2-a}quinoxaline or imidazo{1,
2-a} is a heterocyclic substituent derived from pyrimidine, and E is [Formula] [Formula] [Formula] [Formula] [Formula] or [Formula] [wherein R ₆ is hydrogen, halogen or dialkyl] It is amino, and N is 1-4. R ₇ is hydrogen or halogen]. 2 The imidazo{2,1-b}thiazole substituent is of the formula (), [Formula] () The pyrrolo{1,2-a}benzimidazole substituent is of the formula (Xa) or (Xb), the imidazo{1,2-a}pyridine substituent is of formula (XI), the pyrrolo{2,1-b}benzothiazole substituent is of formula (XIIa) or (XIIb), the pyrrolo{1,2-a}indole substituent is of formula (X), the pyrrolo{1,2-a}imidazole substituent is of formula (Xa) or (Xb), the imidazo{2,1-a}isoquinoline substituent is of formula (X), the pyrrolo{1,2-a}quinoxaline substituent is of formula (Xa) or (Xb), The imidazo{1,2-a}pyrimidine substituent is of formula (X) (In each of the above formulas, R ₈ is optionally substituted aryl or alkyl, R ₉ is hydrogen or alkyl, R ₁₀ is hydrogen, alkyl or aryl, R ₁₁ , R ₁₂ , R ₁₃ and
R ₁₄ are the same or different groups, each being hydrogen, alkyl or nitrogen and R ₁₅ is alkyl. ) Color-forming dye according to claim 1. 3. The chromogenic dye according to claim 1, wherein E is the formula (), A is the formula (), and B is the formula (), (a), (XI) or (XIIa). 4 E is the formula () or (), A is the formula () and B is the formula (), (a), (XI), (XIIa), (
a),
The color-forming dye according to claim 1, which is (), (a) or (). 5. The chromogenic dye according to claim 1, wherein E is the formula () or (), A is the formula (), and B is the formula (), (a) or (XI). 6. The color-forming dye according to any one of claims 1 to 5, wherein the alkyl group or alkyl moiety of the alkyl-containing group has 1 to 12 carbon atoms. 7. The color-forming dye according to claim 6, wherein the alkyl group or alkyl moiety has 1 to 5 carbon atoms. 8. Claim 8 in which the alkyl groups or alkyl moieties are the same or different groups, each of which is methyl, ethyl, n-butyl or isopentyl.
Chromogenic dyes as described in section. 9 Claims 1 to 8 in which the aryl group or aryl moiety of the aryl-containing group is phenyl
The color-forming dye according to any one of paragraphs 1 and 2. 10. The color-forming dye according to claim 2, wherein R ₈ is unsubstituted or para-substituted phenyl. 11 In the presence of a dehydrating agent, a keto acid of formula (XX), Compound of formula (XX) N-H (XX) (wherein one of M and N is A, the other is B,
A is a substituent of formula (), [However, in formula (), R ₄ and R ₅ are the same or different groups, each of which is hydrogen, alkyl or aryl] B is imidazo{2,1-b}thiazole, pyrrolo{1,2-a} Benzimidazole, imidazo{1,2-a}pyridine, pyrrolo{2,1-b}
Benzothiazole, pyrrolo{1,2-a}indole, pyrrolo{1,2-a}imidazole, imidazo{2,1-a}isoquinoline, pyrrolo{1,
2-a}quinoxaline or imidazo{1,2-
a} is a heterocyclic substituent derived from pyrimidine, and E is [Formula] [Formula] [Formula] [Formula] or [Formula], where R ₆ is hydrogen, halogen or dialkyl It is amino, and N is 1-4. R ₇ is hydrogen or halogen. ) A method for producing a lactone-based color-forming dye. 12. The manufacturing method according to claim 11, wherein M is A and N is B. 13. The manufacturing method according to claim 11 or 12, wherein the dehydrating agent is an acid anhydride. 14. The production method according to claim 13, wherein the acid anhydride is acetic anhydride. 15 formula A pressure-sensitive recording material containing a lactone-based color-forming dye. However, in formula (), A is a substituent of formula (), [In formula (), R ₄ and R ₅ are the same or different groups, each of which is hydrogen, alkyl or aryl] B is imidazo{2,1-b}thiazole, pyrrolo{1,2-a}benzimidazole , imidazo{1,2-a}pyridine, pyrrolo{2,1-b}
Benzothiazole, pyrrolo{1,2-a}indole, pyrrolo{1,2-a}imidazole, imidazo{2,1-a}isoquinoline, pyrrolo{1,
2-a}quinoxaline or imidazo{1,2-
a} is a heterocyclic substituent derived from pyrimidine, and E is [Formula] [Formula] [Formula] [Formula] [Formula] or [Formula] [wherein R ₆ is hydrogen, halogen or dialkylamino] Yes, and N is 1-4. R ₇ is hydrogen or halogen]. 16 formula A heat-sensitive recording material containing a lactone-based color-forming dye. However, in formula (), A is a substituent of formula (), [In formula (), R ₄ and R ₅ are the same or different groups, each of which is hydrogen, alkyl or aryl] B is imidazo{2,1-b}thiazole, pyrrolo(1,2-a}benzimidazole , imidazo{1,2-a}pyridine, pyrrolo{2,1-b}
Benzothiazole, pyrrolo{1,2-a}indole, pyrrolo{1,2-a}imidazole, imidazo{2,1-a}isoquinoline, pyrrolo{1,
2-a}quinoxaline or imidazo{1,2-
a} is a heterocyclic substituent derived from pyrimidine, and E is [Formula] [Formula] [Formula] [Formula] [Formula] or [Formula] [wherein R ₆ is hydrogen, halogen or dialkylamino] Yes, and N is 1-4. R ₇ is hydrogen or halogen].